Skip to main content
Equibles

BARCLAYS PLC

Position in BSX — Boston Scientific Corp

CIK 312069 LONDON, X0
Back to BSX Full portfolio

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$315,265,849
-$100,526,131 QoQ
Shares Held
5,024,157
+15.2% QoQ
Ownership
0.338%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.6904356293006.ToString("F0")% Shared 0.ToString("F0")% None 0.3095643706994029.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$59,417,975
CallShares
946,900
PutValue
$29,574,075
PutShares
471,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $2,383,566,932 across 90 Medical Devices names. BSX ranks #4 (13.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MASI
Masimo Corp
 2,743,985 $488,072,611
2 ABT
Abbott Laboratories
 3,876,707 $398,021,505
3 SYK
Stryker Corp
 1,027,154 $337,512,530
4 BSX
Boston Scientific Corp
This page 		5,024,157 $315,265,849
5 MDT
Medtronic plc
 2,755,141 $238,732,965
6 GEHC
GE HealthCare Technologies Inc.
 1,818,661 $129,452,288
7 EW
Edwards Lifesciences Corp
 1,078,481 $86,364,757
8 BIO
Bio-Rad Laboratories, Inc.
 278,835 $77,725,255

All Filings in BSX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $59,417,975 946,900
2026-03-31 $29,574,075 471,300
2026-03-31 $315,265,849 5,024,157
2025-12-31 $415,791,980 4,360,692
2025-12-31 $107,573,870 1,128,200
2025-12-31 $3,003,525 31,500
2025-09-30 $441,282,813 4,519,951
2025-09-30 $12,691,900 130,000
2025-09-30 $3,075,345 31,500
2025-06-30 $469,107,909 4,367,451
2025-06-30 $40,815,800 380,000
2025-06-30 $3,383,415 31,500
2025-03-31 $7,969,520 79,000
2025-03-31 $558,446,761 5,535,753
2025-03-31 $17,502,680 173,500
2024-12-31 $394,285,632 4,414,304
2024-12-31 $15,961,484 178,700
2024-12-31 $8,655,108 96,900
2024-09-30 $341,504,775 4,075,236
2024-09-30 $14,975,060 178,700
2024-09-30 $31,584,220 376,900
2024-06-30 $75,554,511 981,100
2024-06-30 $307,437,241 3,992,173
2024-03-31 $671,202 9,800
2024-03-31 $277,146,016 4,046,518
2023-12-31 $195,092,736 3,374,723
2023-09-30 $220,344,271 4,173,187
2023-06-30 $203,334,746 3,759,193
2023-03-31 $64,901,015 1,297,242
2022-12-31 $3,821,902 82,600
2022-12-31 $101,748,700 2,199,021
2022-09-30 $62,965,024 1,625,743
2022-06-30 $52,129,882 1,398,709
2022-03-31 $9,044,018 204,200
2022-03-31 $90,542,931 2,044,320
2021-12-31 $112,633,551 2,651,449
2021-12-31 $4,073,832 95,900
2021-12-31 $12,744 300
2021-09-30 $13,017 300
2021-09-30 $122,409,479 2,821,145
2021-06-30 $90,546,479 2,117,551
2021-06-30 $12,828 300
2021-03-31 $11,595 300
2021-03-31 $61,592,019 1,593,584
2020-12-31 $56,855,462 1,581,515
2020-12-31 $7,682,515 213,700
2020-12-31 $370,285 10,300
2020-09-30 $10,075,977 263,700
2020-09-30 $62,469,489 1,634,899
2020-09-30 $393,563 10,300

Report a Problem

Category
Description
Email (optional, for follow-up)